prikaz prve stranice dokumenta Extracorporeal blood purification is associated with improvement in biochemical and clinical variables in the critically-ill COVID-19 patients
  Preuzmi
PDF 1.91 MB
Znanstveni rad - Izvorni znanstveni rad
Extracorporeal blood purification is associated with improvement in biochemical and clinical variables in the critically-ill COVID-19 patients
Therapeutic Apheresis and Dialysis, 26 (2022), 2; 316-329. https://doi.org/10.1111/1744-9987.13730
Premužić, Vedran; Babel, Jakša; Gardijan, Danilo; Lapić, Ivana; Gabelica, Rajka; Ostojić, Zvonimir; Lozić, Marin; Pavliša, Gordana; Hrabak, Maja; Knežević, Josip; Rogić, Dunja; Mihaljević, Slobodan

Institucijski repozitorij: Dr Med - digitalni repozitorij Medicinskog fakulteta Sveučilišta u Zagrebu

Citirajte ovaj rad

Premužić, V., Babel, J., Gardijan, D., Lapić, I., Gabelica, R., Ostojić, Z. ... Mihaljević, S. (2022). Extracorporeal blood purification is associated with improvement in biochemical and clinical variables in the critically-ill COVID-19 patients. Therapeutic Apheresis and Dialysis, 26. (2), 316-329. doi: 10.1111/1744-9987.13730

Premužić, Vedran, et al. "Extracorporeal blood purification is associated with improvement in biochemical and clinical variables in the critically-ill COVID-19 patients." Therapeutic Apheresis and Dialysis, vol. 26, br. 2, 2022, str. 316-329. https://doi.org/10.1111/1744-9987.13730

Premužić, Vedran, Jakša Babel, Danilo Gardijan, Ivana Lapić, Rajka Gabelica, Zvonimir Ostojić, Marin Lozić, et al. "Extracorporeal blood purification is associated with improvement in biochemical and clinical variables in the critically-ill COVID-19 patients." Therapeutic Apheresis and Dialysis 26, br. 2 (2022): 316-329. https://doi.org/10.1111/1744-9987.13730

Premužić, V., et al. (2022) 'Extracorporeal blood purification is associated with improvement in biochemical and clinical variables in the critically-ill COVID-19 patients', Therapeutic Apheresis and Dialysis, 26(2), str. 316-329. doi: 10.1111/1744-9987.13730

Premužić V, Babel J, Gardijan D, Lapić I, Gabelica R, Ostojić Z, i sur.. Extracorporeal blood purification is associated with improvement in biochemical and clinical variables in the critically-ill COVID-19 patients. Therapeutic Apheresis and Dialysis [Internet]. 04.2022. [pristupljeno 05.11.2024.];26(2):316-329. doi: 10.1111/1744-9987.13730

V. Premužić, et al., "Extracorporeal blood purification is associated with improvement in biochemical and clinical variables in the critically-ill COVID-19 patients", Therapeutic Apheresis and Dialysis, vol. 26, br. 2, str. 316-329, Travanj 2022. [Online]. Dostupno na: https://urn.nsk.hr/urn:nbn:hr:105:457439. [Citirano: 05.11.2024.]

Za citiranje koristite ovu mrežnu adresu: https://urn.nsk.hr/urn:nbn:hr:105:457439
Podaci o radu
Naslov (engleski)Extracorporeal blood purification is associated with improvement in biochemical and clinical variables in the critically-ill COVID-19 patients
AutorVedran Premužić
AutorJakša Babel
AutorDanilo Gardijan
AutorIvana Lapić
AutorRajka Gabelica
AutorZvonimir Ostojić
AutorMarin Lozić
AutorGordana Pavliša
AutorMaja Hrabak
AutorJosip Knežević
AutorDunja Rogić
AutorSlobodan Mihaljević
Autorova ustanovaSveučilište u Zagrebu
Medicinski fakultet
(KATEDRA ZA ANESTEZIOLOGIJU, REANIMATOLOGIJU I INTENZIVNU MEDICINU KIRURŠKIH STRUKA)
Znanstveno / umjetničko
područje, polje i grana		BIOMEDICINA I ZDRAVSTVO
Kliničke medicinske znanosti
Anesteziologija i reanimatologija
Sažetak (engleski)
This study tried to investigate the impact of oXiris filter on both clinical and laboratory parameters in critically-ill COVID-19 intensive care unit (ICU) patients receiving extracorporeal blood purification and the clinical setting for the initiation of therapy. A consecutive sample of 15 ICU patients with COVID-19 was treated with oXiris membrane for blood purification or for support of renal function due to acute kidney injury. We have included 19 non treated ICU COVID-19 patients as a control group. Two chest x-rays were analyzed for determining the chest x-ray severity score. We have found a significant decrease of SOFA score, respiratory status improved and the chest x-ray severity score was significantly decreased after 72 h of treatment. IL-6 significantly decreased after 72 h of treatment while other inflammatory markers did not. Respiratory status in the control group worsened as well as increase in SOFA score and chest x-ray severity score. Survived patients have shorter time from the onset of symptoms before starting with extracorporeal blood purification treatment and shorter time on vasoactive therapy and invasive respiratory support than deceased patients. Critically-ill patients with COVID-19 treated with extracorporeal blood purification survived significantly longer than other ICU COVID-19 patients. Treatment with oXiris membrane provides significant reduction of IL-6, leads to improvement in respiratory status, chest x-ray severity score, and reduction of SOFA score severity. Our results can suggest that ICU COVID-19 patients in an early course of a disease could be potentially a target group for earlier initiation of extracorporeal blood purification.
Ključne riječi (engleski)
Jezikengleski
Vrsta publikacijeZnanstveni rad - Izvorni znanstveni rad
Status objaveObjavljen
Vrsta recenzijeRecenziran
Verzija publikacijeObjavljena verzija rada (izdavačev PDF)
Naslov časopisaTherapeutic Apheresis and Dialysis
Brojčani podacivol. 26, br. 2, str. 316-329
p-ISSN1744-9979
e-ISSN1744-9987
DOIhttps://doi.org/10.1111/1744-9987.13730
URN:NBNurn:nbn:hr:105:457439
Datum objave publikacije2022-04
URL dokumentahttps://onlinelibrary.wiley.com/doi/10.1111/1744-9987.13730
Vrsta resursaTekst
Prava pristupaOtvoreni pristup
Uvjeti korištenjaIkona licence Zaštićeno autorskim pravom.
Datum i vrijeme pohrane2022-06-28 08:38:20